These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18240803)

  • 21. HIV prophylaxis expensive and sometimes difficult to obtain.
    Silversides A
    CMAJ; 2006 Nov; 175(11):1359. PubMed ID: 17116896
    [No Abstract]   [Full Text] [Related]  

  • 22. Global AIDS epidemic: getting things done.
    James JS
    AIDS Treat News; 2001 Jun; (367):7. PubMed ID: 11548660
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug firms drop drug case against South Africa.
    AIDS Policy Law; 2001 May; 16(9):3. PubMed ID: 11668825
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinton Foundation negotiates $140/Year HIV treatment, but U.S. won't buy.
    James JS
    AIDS Treat News; 2004 Mar; (399):2-4. PubMed ID: 15199865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS activists decry steady hikes in HIV drug prices.
    AIDS Policy Law; 2005 Jul; 20(14):1, 4. PubMed ID: 16110523
    [No Abstract]   [Full Text] [Related]  

  • 26. A remedy beyond lower cost drugs.
    Zuniga JM
    IAPAC Mon; 2001 Sep; 7(9):267. PubMed ID: 11708270
    [No Abstract]   [Full Text] [Related]  

  • 27. Twenty-five years in the fight against AIDS: what have we learned?
    Proj Inf Perspect; 2006 Oct; (42):1-3. PubMed ID: 17162804
    [No Abstract]   [Full Text] [Related]  

  • 28. Summaries for patients. Adherence to HIV treatment and costs of care.
    Ann Intern Med; 2010 Jan; 152(1):I-50. PubMed ID: 20048265
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs should be affordable to India's poor to fight HIV/AIDS.
    Agoramoorthy G; Hsu MJ
    AIDS; 2006 Oct; 20(15):1988-9. PubMed ID: 16988526
    [No Abstract]   [Full Text] [Related]  

  • 30. Glaxo drops drug prices, AIDS foundation drops suit.
    AIDS Policy Law; 2003 May; 18(10):6. PubMed ID: 12809097
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinton team lowers drug price 7-fold in Caribbean.
    James JS
    AIDS Treat News; 2003 Mar; (389):7-8. PubMed ID: 12712939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy watch. Profitable pills.
    Gebbie KM
    AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment. HIV drug spending up; Merck offers discounts.
    AIDS Policy Law; 2010 Jun; 25(7):1. PubMed ID: 20607912
    [No Abstract]   [Full Text] [Related]  

  • 34. ADAP. Group presses for price concessions on AIDS drugs.
    AIDS Policy Law; 2003 Jun; 18(12):5. PubMed ID: 12846185
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV treatment costs balloon for clinics as funding remains flat. ART costs are the highest, research shows.
    AIDS Alert; 2009 Apr; 24(4):37-9. PubMed ID: 19382361
    [No Abstract]   [Full Text] [Related]  

  • 36. US disburses first round of AIDS funds.
    Surendran A
    Nat Med; 2004 Apr; 10(4):323. PubMed ID: 15156586
    [No Abstract]   [Full Text] [Related]  

  • 37. Out of Thailand, into Africa.
    Clayton J
    Nature; 2004 Jul; 430(6996):136-7. PubMed ID: 15241384
    [No Abstract]   [Full Text] [Related]  

  • 38. Women see little hope of anti-retroviral treatment yet.
    Wanyama C
    Bull World Health Organ; 2002; 80(7):607. PubMed ID: 12163932
    [No Abstract]   [Full Text] [Related]  

  • 39. Policy watching.
    Gebbie KM
    AIDS Read; 2001 May; 11(5):252, 259. PubMed ID: 11392693
    [No Abstract]   [Full Text] [Related]  

  • 40. Paying for life. The issues behind drug pricing.
    Huff B
    GMHC Treat Issues; 2003 Nov; 17(11):1-7. PubMed ID: 14717105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.